Kontakt
LUNIRI Gemeinnützige GmbH
Hauptstraße 117
10827 Berlin, GERMANY
E-Mail: info(at)luniri.com
Steffen Frese, the founder of LUNIRI, received new research funding from the German Research Foundation. http://gepris.dfg.de/gepris/projekt/317392477?language=en Research will be conducted at the German Rheumatism Research Centre in Berlin, Germany.&nb ... Read More
Berlin Marathon 2017http://lupusnewstoday.com/2016/11/11/irinotecan-topo-1-blocker-seen-as-potential-lupus-specific-treatment
Neue Ergebnisse aus der Forschung veröffentlich in Arthritis Research & TherapySuppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan. Arthritis Res Ther. 2016 Oct 22; 18(1):243
New scientific data published in Arthritis Research & TherapySuppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan. Arthritis Res Ther. 2016 Oct 22; 18(1):243
Cancelation of credit card paymentDue to the absence of donations for LUNIRI in the context of monthly operating costs, transfer of donation by credit card will be canceled from 1st of June 2016. We deeply regret this development.
More Blog EntriesLUNIRI Gemeinnützige GmbH
Hauptstraße 117
10827 Berlin, GERMANY
E-Mail: info(at)luniri.com